FDA Orders Nationwide Recall of Grey Goose, Belvedere, and All Premium Vodka Brands After Toxic Filtration Chemical Detected

WASHINGTON — The U.S. Food and Drug Administration issued an emergency recall order Tuesday covering virtually every premium vodka brand sold in the United States, after laboratory testing revealed the presence of a carcinogenic compound introduced during the charcoal filtration process used exclusively by high-end producers.

The recall affects Grey Goose, Belvedere, Chopin, Stolichnaya Elit, Cîroc, and at least 14 other premium vodka brands that retail for $30 or more per bottle. Budget vodka brands, which use a different filtration process, are not affected. The FDA estimates that approximately 22 million bottles currently in homes, bars, and retail locations are subject to the recall.

'The compound in question — hexavalent chromium — was introduced through industrial-grade activated charcoal filters that premium vodka producers use to achieve their signature smoothness,' said the FDA Commissioner in a press conference. 'Ironically, the very process that makes expensive vodka taste "cleaner" has been contaminating it with a known carcinogen.'

The FDA is advising consumers to immediately stop drinking any premium vodka purchased since January 2024 and to dispose of all open and unopened bottles. The agency has set up a dedicated website where consumers can check whether their specific bottle is affected by entering the lot number printed on the back label.

Liquor stores and bars in Los Angeles have already begun pulling premium vodka from shelves. Several high-end nightclubs in West Hollywood and Beverly Hills have announced they will temporarily suspend vodka service entirely. 'Our clientele expects the best, and right now we can't guarantee that,' said the manager of a prominent Sunset Boulevard establishment.

The recall has sent shockwaves through the spirits industry, with shares of major liquor conglomerates dropping 8-12% in pre-market trading. Industry analysts estimate the recall could cost producers upward of $2.4 billion in lost revenue and legal liability.

Consumers who have experienced symptoms such as persistent stomach discomfort, unusual fatigue, or metallic taste after consuming premium vodka are urged to contact their healthcare provider and file a report with the FDA's MedWatch program.